Strong Buy
Buy
Hold
Sell
Strong Sell
Consensus
| Date | Grading Company | New Grade | Previous Grade | Action | Price When Posted | News Title | Publisher |
|---|---|---|---|---|---|---|---|
| 2025-11-14 | Raymond James | Outperform | Outperform | Hold | $29.59 | Fulgent Genetics (FLGT) PT Raised to $36 at Raymond James | StreetInsider |
| 2025-08-05 | UBS | Buy | Neutral | Upgrade | $20.78 | Fulgent Genetics upgraded to Buy from Neutral at UBS | TheFly |
| 2025-05-06 | Piper Sandler | Neutral | Neutral | Hold | $19.02 | Fulgent Genetics price target raised to $23 from $16 at Pip… | TheFly |
| 2025-05-05 | Raymond James | Outperform | Outperform | Hold | $19.56 | Fulgent Genetics price target raised to $25 from $24 at Ray… | TheFly |
| 2025-03-02 | UBS | Neutral | Neutral | Hold | $15.45 | Fulgent Genetics price target lowered to $20 from $27 at UBS | TheFly |
| 2022-12-08 | Piper Sandler | Neutral | Overweight | Downgrade | $37.07 | Piper Sandler Downgrades Fulgent Genetics to Neutral, Lower… | Benzinga |
| 2022-11-18 | Raymond James | Outperform | N/A | Initialise | $35.89 | Raymond James Initiates Coverage On Fulgent Genetics with O… | Benzinga |
| 2022-11-14 | Piper Sandler | Overweight | Overweight | Hold | $39.24 | Piper Sandler Maintains Overweight on Fulgent Genetics, Low… | Benzinga |